375 related articles for article (PubMed ID: 2882835)
1. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
3. Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha.
Verstovsek S; Maccubbin D; Ehrke MJ; Mihich E
Cancer Res; 1992 Jul; 52(14):3880-5. PubMed ID: 1617664
[TBL] [Abstract][Full Text] [Related]
4. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
5. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
[TBL] [Abstract][Full Text] [Related]
6. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.
Talmadge JE; Tribble HR; Pennington RW; Phillips H; Wiltrout RH
Cancer Res; 1987 May; 47(10):2563-70. PubMed ID: 3105865
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
Bermudez LE; Young LS
J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway.
Paulnock DM; Lambert LE
J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906
[TBL] [Abstract][Full Text] [Related]
11. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
12. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.
Belosevic M; Davis CE; Meltzer MS; Nacy CA
J Immunol; 1988 Aug; 141(3):890-6. PubMed ID: 3135315
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
Chen L; Suzuki Y; Wheelock EF
J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
Jun CD; Yoon HJ; Kim HM; Chung HT
Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
[TBL] [Abstract][Full Text] [Related]
15. Role of tumor necrosis factor in macrophage activation and tumoricidal activity.
Mace KF; Ehrke MJ; Hori K; Maccubbin DL; Mihich E
Cancer Res; 1988 Oct; 48(19):5427-32. PubMed ID: 3416299
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor as a potent effector molecule for tumor cell killing by activated rat peritoneal macrophages in vitro.
Kusenda J; Kalafut F; Klobusická M; Novotná L
Neoplasma; 1992; 39(1):23-8. PubMed ID: 1528301
[TBL] [Abstract][Full Text] [Related]
17. Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon-gamma or a calcium ionophore.
Akagawa KS; Kamoshita K; Onodera S; Tokunaga T
Jpn J Cancer Res; 1987 Mar; 78(3):279-87. PubMed ID: 3106284
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
Drapier JC; Wietzerbin J; Hibbs JB
Eur J Immunol; 1988 Oct; 18(10):1587-92. PubMed ID: 3142779
[TBL] [Abstract][Full Text] [Related]
19. Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin.
Mace K; Mayhew E; Mihich E; Ehrke MJ
Cancer Res; 1988 Jan; 48(1):130-6. PubMed ID: 3257160
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
